Pathologic Staging (pTNM)
CAP Approved Endocrine • Thyroid Gland 4.0.0.0(AJCC 8th ed.)
___ m (multiple primary tumors)
___ r (recurrent)
___ y (posttreatment)
For Papillary, Follicular, Poorly Differentiated, Hurthle Cell and Anaplastic Thyroid Carcinoma
Primary Tumor (pT)
___ pTX: Primary tumor cannot be assessed
___ pT0: No evidence of primary tumor
___ pT1: Tumor ≤2 in greatest dimension, limited to the thyroid
___ pT1a: Tumor ≤1 cm in greatest dimension limited to the thyroid
___ pT1b: Tumor >1 cm but ≤2 cm in greatest dimension, limited to the thyroid
___ pT2: Tumor >2 cm, but ≤4 cm in greatest dimension, limited to thyroid
___ pT3: Tumor >4 cm limited to the thyroid, or gross extrathyroidal extension invading only strap muscles
___ pT3a: Tumor >4 cm limited to the thyroid
___ pT3b: Gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid, or omohyoid muscles) from a tumor of any size
___ pT4: Includes gross extrathyroidal extension beyond the strap muscles
___ pT4a: Gross extrathyroidal extension invading subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve from a tumor of any size
___ pT4b: Gross extrathyroidal extension invading prevertebral fascia or encasing the carotid artery or mediastinal vessels from a tumor of any size
Note: There is no category of carcinoma in situ (pTis) relative to carcinomas of thyroid gland.
For Medullary Thyroid Carcinoma
Primary Tumor (pT)
___ pTX: Primary tumor cannot be assessed
___ pT0: No evidence of primary tumor
___ pT1: Tumor ≤2 in greatest dimension, limited to the thyroid
___ pT1a: Tumor ≤1 cm in greatest dimension limited to the thyroid
___ pT1b: Tumor >1 cm but ≤2 cm in greatest dimension, limited to the thyroid
___ pT2: Tumor >2 cm, but ≤4 cm in greatest dimension, limited to thyroid
___ pT3: Tumor >4 cm or with extrathyroidal extension
___ pT3a: Tumor >4 cm in greatest dimension limited to the thyroid
___ pT3b: Tumor of any size with gross extrathyroidal extension invading only strap muscles (sternohyoid, sternothyroid, thyrohyoid or omohyoid muscles)
___pT4: Advanced disease
___pT4a: Moderately advanced disease; tumor of any size with gross extrathyroidal extension into the nearby tissues of the neck, including subcutaneous soft tissue, larynx, trachea, esophagus, or recurrent laryngeal nerve
___pT4b: Very advanced disease; tumor of any size with extension toward the spine or into nearby large blood vessels, gross extrathyroidal extension invading the prevertebral fascia, or encasing the carotid artery or mediastinal vessels
For All Carcinomas of the Thyroid
Regional Lymph Nodes (pN)#
___ pNX: Regional lymph nodes cannot be assessed
___ pN0a: One or more cytologically or histologically confirmed benign lymph nodes
___ pN1: Metastasis to regional nodes
___ pN1a: Metastasis to level VI or VII (pretracheal, paratracheal, or prelaryngeal/Delphian, or upper mediastinal) lymph nodes. This can be unilateral or bilateral disease.
___ pN1b: Metastasis to unilateral, bilateral, or contralateral lateral neck lymph nodes (levels I, II, III, IV, or V) or retropharyngeal lymph nodes
# N0b is defined as no radiologic or clinical evidence of locoregional lymph node metastasis.
For All Carcinomas of the Thyroid
Distant Metastasis (pM) (required only if confirmed pathologically in this case)
___ pM1: Distant metastasis
Specify site(s), if known: ____________________________
Thyroid CAP 4.0.0.0 Summary of pTNM changes AJCC 7th to 8th ed.